DiscoverRedefinersRisk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo
Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Update: 2022-07-13
Share

Description

Take risks, keep learning, and stay calm. It’s how our guest, Stryker Chair and CEO Kevin Lobo, became arguably one of the most successful CEOs ever. We’ll talk with the Indian-born, Canadian-raised, internationally acclaimed businessperson about how he became known as the “Godfather of MedTech” and as an acquisitions deal maker. We’ll hear how Kevin’s high threshold for risk helped Stryker drastically outpace the competition and how he built his Board’s trust to make more than 55 acquisitions. Kevin also shares his insights on timely topics leaders in all industries are talking about: technology, crisis management, company culture, and how to keep employees happy, purpose-driven, and loyal.   



If you liked this episode, check out these other Redefiner episodes:
·  Trust Your Gut: AXA’s Thomas Buberl Talks Transformation and Reinvention
·  How to Lead Like a Legend with Samuel Tsien
·  Confessions of a Serial Entrepreneur with Mario Schlosser 

BIO: Kevin A. Lobo, Chair and CEO, Stryker
Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics. Mr. Lobo serves on the board of directors for Parker Hannifin Corporation (NYSE:PH), the Advanced Medical Technology Association (AdvaMed) and the U.S.-India Business Council. He is also a member of the Business Roundtable and Business Council.


Mr. Lobo has a broad business career across multiple industries. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including roles based in Europe as Corporate Controller of a chemical spin-out and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President of Ethicon Endo Surgery.

Comments (1)

text

text

Sep 9th
Reply
loading
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Russell Reynolds Associates